170 related articles for article (PubMed ID: 24646362)
1. Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer.
Crew KD; Ho KA; Brown P; Greenlee H; Bevers TB; Arun B; Sneige N; Hudis C; McArthur HL; Chang J; Rimawi M; Cornelison TL; Cardelli J; Santella RM; Wang A; Lippman SM; Hershman DL
J Hum Nutr Diet; 2015 Jun; 28(3):272-82. PubMed ID: 24646362
[TBL] [Abstract][Full Text] [Related]
2. Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer.
Crew KD; Brown P; Greenlee H; Bevers TB; Arun B; Hudis C; McArthur HL; Chang J; Rimawi M; Vornik L; Cornelison TL; Wang A; Hibshoosh H; Ahmed A; Terry MB; Santella RM; Lippman SM; Hershman DL
Cancer Prev Res (Phila); 2012 Sep; 5(9):1144-54. PubMed ID: 22827973
[TBL] [Abstract][Full Text] [Related]
3. Effects of green tea catechin extract on serum lipids in postmenopausal women: a randomized, placebo-controlled clinical trial.
Samavat H; Newman AR; Wang R; Yuan JM; Wu AH; Kurzer MS
Am J Clin Nutr; 2016 Dec; 104(6):1671-1682. PubMed ID: 27806972
[TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities.
Nguyen MM; Ahmann FR; Nagle RB; Hsu CH; Tangrea JA; Parnes HL; Sokoloff MH; Gretzer MB; Chow HH
Cancer Prev Res (Phila); 2012 Feb; 5(2):290-8. PubMed ID: 22044694
[TBL] [Abstract][Full Text] [Related]
5. The Minnesota Green Tea Trial (MGTT), a randomized controlled trial of the efficacy of green tea extract on biomarkers of breast cancer risk: study rationale, design, methods, and participant characteristics.
Samavat H; Dostal AM; Wang R; Bedell S; Emory TH; Ursin G; Torkelson CJ; Gross MD; Le CT; Yu MC; Yang CS; Yee D; Wu AH; Yuan JM; Kurzer MS
Cancer Causes Control; 2015 Oct; 26(10):1405-19. PubMed ID: 26206423
[TBL] [Abstract][Full Text] [Related]
6. Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro.
McLarty J; Bigelow RL; Smith M; Elmajian D; Ankem M; Cardelli JA
Cancer Prev Res (Phila); 2009 Jul; 2(7):673-82. PubMed ID: 19542190
[TBL] [Abstract][Full Text] [Related]
7. Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women.
Wu AH; Spicer D; Stanczyk FZ; Tseng CC; Yang CS; Pike MC
Cancer Prev Res (Phila); 2012 Mar; 5(3):393-402. PubMed ID: 22246619
[TBL] [Abstract][Full Text] [Related]
8. Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy.
Zhang G; Wang Y; Zhang Y; Wan X; Li J; Liu K; Wang F; Liu K; Liu Q; Yang C; Yu P; Huang Y; Wang S; Jiang P; Qu Z; Luan J; Duan H; Zhang L; Hou A; Jin S; Hsieh TC; Wu E
Curr Mol Med; 2012 Feb; 12(2):163-76. PubMed ID: 22280355
[TBL] [Abstract][Full Text] [Related]
9. Polyphenon E, non-futile at neuroprotection in multiple sclerosis but unpredictably hepatotoxic: Phase I single group and phase II randomized placebo-controlled studies.
Lovera J; Ramos A; Devier D; Garrison V; Kovner B; Reza T; Koop D; Rooney W; Foundas A; Bourdette D
J Neurol Sci; 2015 Nov; 358(1-2):46-52. PubMed ID: 26298797
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.
Chow HH; Cai Y; Hakim IA; Crowell JA; Shahi F; Brooks CA; Dorr RT; Hara Y; Alberts DS
Clin Cancer Res; 2003 Aug; 9(9):3312-9. PubMed ID: 12960117
[TBL] [Abstract][Full Text] [Related]
11. Phase IIa chemoprevention trial of green tea polyphenols in high-risk individuals of liver cancer: modulation of urinary excretion of green tea polyphenols and 8-hydroxydeoxyguanosine.
Luo H; Tang L; Tang M; Billam M; Huang T; Yu J; Wei Z; Liang Y; Wang K; Zhang ZQ; Zhang L; Wang JS
Carcinogenesis; 2006 Feb; 27(2):262-8. PubMed ID: 15930028
[TBL] [Abstract][Full Text] [Related]
12. The safety of green tea extract supplementation in postmenopausal women at risk for breast cancer: results of the Minnesota Green Tea Trial.
Dostal AM; Samavat H; Bedell S; Torkelson C; Wang R; Swenson K; Le C; Wu AH; Ursin G; Yuan JM; Kurzer MS
Food Chem Toxicol; 2015 Sep; 83():26-35. PubMed ID: 26051348
[TBL] [Abstract][Full Text] [Related]
13. Phase Ib Study of Chemoprevention with Green Tea Polyphenon E and Erlotinib in Patients with Advanced Premalignant Lesions (APL) of the Head and Neck.
Shin DM; Nannapaneni S; Patel MR; Shi Q; Liu Y; Chen Z; Chen AY; El-Deiry MW; Beitler JJ; Steuer CE; Roser SM; Klein AM; Owonikoko TK; Ramalingam SS; Khuri FR; Chen ZG; Saba NF
Clin Cancer Res; 2020 Nov; 26(22):5860-5868. PubMed ID: 32943457
[TBL] [Abstract][Full Text] [Related]
14. Preventive effects of polyphenon E on urinary bladder and mammary cancers in rats and correlations with serum and urine levels of tea polyphenols.
Lubet RA; Yang CS; Lee MJ; Hara Y; Kapetanovic IM; Crowell JA; Steele VE; Juliana MM; Grubbs CJ
Mol Cancer Ther; 2007 Jul; 6(7):2022-8. PubMed ID: 17620432
[TBL] [Abstract][Full Text] [Related]
15. Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia.
Sinicrope FA; Viggiano TR; Buttar NS; Song LMWK; Schroeder KW; Kraichely RE; Larson MV; Sedlack RE; Kisiel JB; Gostout CJ; Kalaiger AM; Patai ÁV; Della'Zanna G; Umar A; Limburg PJ; Meyers JP; Foster NR; Yang CS; Sontag S
Cancer Prev Res (Phila); 2021 May; 14(5):573-580. PubMed ID: 33648940
[TBL] [Abstract][Full Text] [Related]
16. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals.
Chow HH; Hakim IA; Vining DR; Crowell JA; Ranger-Moore J; Chew WM; Celaya CA; Rodney SR; Hara Y; Alberts DS
Clin Cancer Res; 2005 Jun; 11(12):4627-33. PubMed ID: 15958649
[TBL] [Abstract][Full Text] [Related]
17. Green tea catechins inhibit angiogenesis through suppression of STAT3 activation.
Leong H; Mathur PS; Greene GL
Breast Cancer Res Treat; 2009 Oct; 117(3):505-15. PubMed ID: 18821062
[TBL] [Abstract][Full Text] [Related]
18. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
[TBL] [Abstract][Full Text] [Related]
19. Effect of green tea extract on arterial stiffness, lipid profile and sRAGE in patients with type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled trial.
Quezada-Fernández P; Trujillo-Quiros J; Pascoe-González S; Trujillo-Rangel WA; Cardona-Müller D; Ramos-Becerra CG; Barocio-Pantoja M; Rodríguez-de la Cerda M; Nérida Sánchez-Rodríguez E; Cardona-Muñóz EG; García-Benavides L; Grover-Páez F
Int J Food Sci Nutr; 2019 Dec; 70(8):977-985. PubMed ID: 31084381
[TBL] [Abstract][Full Text] [Related]
20. Effect of Green Tea Supplements on Liver Enzyme Elevation: Results from a Randomized Intervention Study in the United States.
Yu Z; Samavat H; Dostal AM; Wang R; Torkelson CJ; Yang CS; Butler LM; Kensler TW; Wu AH; Kurzer MS; Yuan JM
Cancer Prev Res (Phila); 2017 Oct; 10(10):571-579. PubMed ID: 28765194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
